Research ExplorerPublicationsEffective prevention of recurrent dislocation following prim...

Effective prevention of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip arthroplasty using a posterior lip augmentation device

Standard

Effective prevention of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip arthroplasty using a posterior lip augmentation device. / Schmidl, S; Jakobs, O; Guenther, D; Lausmann, C; Schoof, B; Beckmann, J; Gehrke, T; Gebauer, M.

In: ARCH ORTHOP TRAUM SU, Vol. 136, No. 4, 04.2016, p. 579-83.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schmidl, S, Jakobs, O, Guenther, D, Lausmann, C, Schoof, B, Beckmann, J, Gehrke, T & Gebauer, M 2016, 'Effective prevention of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip arthroplasty using a posterior lip augmentation device', ARCH ORTHOP TRAUM SU, vol. 136, no. 4, pp. 579-83. https://doi.org/10.1007/s00402-016-2415-y

APA

Schmidl, S., Jakobs, O., Guenther, D., Lausmann, C., Schoof, B., Beckmann, J., Gehrke, T., & Gebauer, M. (2016). Effective prevention of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip arthroplasty using a posterior lip augmentation device. ARCH ORTHOP TRAUM SU, 136(4), 579-83. https://doi.org/10.1007/s00402-016-2415-y

Vancouver

Schmidl S, Jakobs O, Guenther D, Lausmann C, Schoof B, Beckmann J et al. Effective prevention of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip arthroplasty using a posterior lip augmentation device. ARCH ORTHOP TRAUM SU. 2016 Apr;136(4):579-83. https://doi.org/10.1007/s00402-016-2415-y

Bibtex

@article{5cf0dbc5583a4bf992346602de21aade,
title = "Effective prevention of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip arthroplasty using a posterior lip augmentation device",
abstract = "PURPOSE: This retrospective study was performed to determine the effectiveness of preventing recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip replacement using a posterior lip augmentation device (PLAD).METHODS: Between January 2003 and Dezember 2006, 27 PLADs were used in the treatment of recurrent hip dislocation in 27 patients who had received a cemented primary total hip arthroplasty using Endo-MarkIII/SP2 (Waldemar LINK, Hamburg, Germany) components. The mean number of dislocations prior to stabilization with this specific device was 2.6 (range 2-4, SD ± 0.4) with a mean time to revision surgery of 10 months (IQR 13). The mean age of the patients at time of revision surgery was 81.5 years (range 70-94, SD ± 6.9). The control group evaluating the clinical outcome using the Harris Hip Score (HHS) also received a cemented primary total hip arthroplasty using the same implants. A retrospective clinical and radiological review was carried out at a mean follow-up of 68.5 months (range 30-103, SD ± 17.7).RESULTS: Of the 27 patients, 6 had died at the time of the latest review, with the posterior lip augmentation device still in situ and without reported further dislocation after PLAD application. In 2 of the remaining 21 patients recurrent dislocation occurred, thus a subsequent revision of respective implants had to be performed to achieve persistent joint stability. At latest follow-up no deep infection or implant loosening occurred.CONCLUSION: Surgical treatment of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip replacement using a posterior lip augmentation device is a safe and effective procedure which can lead to a secondary stabilization of the total hip arthroplasty in about 90 % of the patients.",
keywords = "Aged, Aged, 80 and over, Arthroplasty, Replacement, Hip, Female, Follow-Up Studies, Hip Dislocation, Hip Prosthesis, Humans, Male, Postoperative Complications, Prostheses and Implants, Reoperation, Retrospective Studies, Treatment Outcome, Journal Article",
author = "S Schmidl and O Jakobs and D Guenther and C Lausmann and B Schoof and J Beckmann and T Gehrke and M Gebauer",
year = "2016",
month = apr,
doi = "10.1007/s00402-016-2415-y",
language = "English",
volume = "136",
pages = "579--83",
journal = "ARCH ORTHOP TRAUM SU",
issn = "0936-8051",
publisher = "Springer",
number = "4",

}

RIS

TY - JOUR

T1 - Effective prevention of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip arthroplasty using a posterior lip augmentation device

AU - Schmidl, S

AU - Jakobs, O

AU - Guenther, D

AU - Lausmann, C

AU - Schoof, B

AU - Beckmann, J

AU - Gehrke, T

AU - Gebauer, M

PY - 2016/4

Y1 - 2016/4

N2 - PURPOSE: This retrospective study was performed to determine the effectiveness of preventing recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip replacement using a posterior lip augmentation device (PLAD).METHODS: Between January 2003 and Dezember 2006, 27 PLADs were used in the treatment of recurrent hip dislocation in 27 patients who had received a cemented primary total hip arthroplasty using Endo-MarkIII/SP2 (Waldemar LINK, Hamburg, Germany) components. The mean number of dislocations prior to stabilization with this specific device was 2.6 (range 2-4, SD ± 0.4) with a mean time to revision surgery of 10 months (IQR 13). The mean age of the patients at time of revision surgery was 81.5 years (range 70-94, SD ± 6.9). The control group evaluating the clinical outcome using the Harris Hip Score (HHS) also received a cemented primary total hip arthroplasty using the same implants. A retrospective clinical and radiological review was carried out at a mean follow-up of 68.5 months (range 30-103, SD ± 17.7).RESULTS: Of the 27 patients, 6 had died at the time of the latest review, with the posterior lip augmentation device still in situ and without reported further dislocation after PLAD application. In 2 of the remaining 21 patients recurrent dislocation occurred, thus a subsequent revision of respective implants had to be performed to achieve persistent joint stability. At latest follow-up no deep infection or implant loosening occurred.CONCLUSION: Surgical treatment of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip replacement using a posterior lip augmentation device is a safe and effective procedure which can lead to a secondary stabilization of the total hip arthroplasty in about 90 % of the patients.

AB - PURPOSE: This retrospective study was performed to determine the effectiveness of preventing recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip replacement using a posterior lip augmentation device (PLAD).METHODS: Between January 2003 and Dezember 2006, 27 PLADs were used in the treatment of recurrent hip dislocation in 27 patients who had received a cemented primary total hip arthroplasty using Endo-MarkIII/SP2 (Waldemar LINK, Hamburg, Germany) components. The mean number of dislocations prior to stabilization with this specific device was 2.6 (range 2-4, SD ± 0.4) with a mean time to revision surgery of 10 months (IQR 13). The mean age of the patients at time of revision surgery was 81.5 years (range 70-94, SD ± 6.9). The control group evaluating the clinical outcome using the Harris Hip Score (HHS) also received a cemented primary total hip arthroplasty using the same implants. A retrospective clinical and radiological review was carried out at a mean follow-up of 68.5 months (range 30-103, SD ± 17.7).RESULTS: Of the 27 patients, 6 had died at the time of the latest review, with the posterior lip augmentation device still in situ and without reported further dislocation after PLAD application. In 2 of the remaining 21 patients recurrent dislocation occurred, thus a subsequent revision of respective implants had to be performed to achieve persistent joint stability. At latest follow-up no deep infection or implant loosening occurred.CONCLUSION: Surgical treatment of recurrent dislocation following primary cemented Endo-MarkIII/SP2 total hip replacement using a posterior lip augmentation device is a safe and effective procedure which can lead to a secondary stabilization of the total hip arthroplasty in about 90 % of the patients.

KW - Aged

KW - Aged, 80 and over

KW - Arthroplasty, Replacement, Hip

KW - Female

KW - Follow-Up Studies

KW - Hip Dislocation

KW - Hip Prosthesis

KW - Humans

KW - Male

KW - Postoperative Complications

KW - Prostheses and Implants

KW - Reoperation

KW - Retrospective Studies

KW - Treatment Outcome

KW - Journal Article

U2 - 10.1007/s00402-016-2415-y

DO - 10.1007/s00402-016-2415-y

M3 - SCORING: Journal article

C2 - 26946002

VL - 136

SP - 579

EP - 583

JO - ARCH ORTHOP TRAUM SU

JF - ARCH ORTHOP TRAUM SU

SN - 0936-8051

IS - 4

ER -